Efficacy and Safety of Basal Insulin + Two to Three Oral Antihyperglycaemic Drugs vs Twice-Daily Premixed Insulin + Metformin After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of a basal insulin + 2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin + metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, randomized controlled BEYOND-V trial
Diabetes Obes Metab 2022 Oct 01;24(10)1957-1966, Q Pan, Y Li, H Wan, J Wang, B Xu, G Wang, C Jiang, L Liang, W Feng, J Liu, T Wang, X Zhang, N Cui, Y Mu, L GuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.